Melflufen for relapsed and refractory multiple myeloma

Oriol, A; Larocca, A; Leleu, X; Hajek, R; Hassoun, H; Rodriguez-Otero, P; Paner, A; Schjesvold, FH; Gullbo, J; Richardson, PG

Richardson, PG (corresponding author), Dana Farber Canc Inst, Boston, MA 02215 USA.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020; 29 (10): 1069

Abstract

Introduction: The overall survival of patients with multiple myeloma has improved with the advent of novel agents; however, multiple myeloma remains i......

Full Text Link